当前位置:首页 - 行情中心 - 春立医疗(688236) - 财务分析 - 利润表

春立医疗

(688236)

  

流通市值:11.17亿  总市值:54.04亿
流通股本:7929.47万   总股本:3.84亿

利润表

报告期2024-06-302024-03-312023-12-312023-09-30
公司类型通用通用通用通用
一、营业总收入380,130,570.92221,850,180.791,208,523,845.88792,155,559.31
营业收入380,130,570.92221,850,180.791,208,523,845.88792,155,559.31
二、营业总成本304,028,844.65164,450,441.62911,961,036.54607,002,161.57
营业成本108,247,815.4658,041,719.59332,635,741.48232,370,997.62
税金及附加4,342,874.751,832,378.1810,850,629.275,742,326.79
销售费用111,481,168.863,145,976.61383,140,145.99233,751,182.69
管理费用21,310,062.047,522,645.7244,471,023.128,910,652.58
研发费用67,659,413.0634,991,868.71157,445,504.26114,743,907.65
财务费用-9,012,489.46-1,084,147.19-16,582,007.56-8,516,905.76
其中:利息费用27,050.23-85,896.4548,115.37
其中:利息收入8,040,034.971,263,505.1114,461,912.368,164,883.5
加:公允价值变动收益4,670,205.471,380,799.849,610,896.667,071,744.6
加:投资收益6,084,909.583,286,525.2112,012,452.0610,067,668.5
资产处置收益39,213.61-3,904.6-549.43
资产减值损失(新)-5,229,285.17-26,245.26-20,707,206.43-3,175,940.28
信用减值损失(新)-5,794,060.61-5,451,806.83-4,315,237.96-8,302,884.2
其他收益6,413,483.272,736,455.1612,807,845.265,119,584.73
营业利润平衡项目0000
四、营业利润82,286,192.4259,325,467.29305,975,463.53195,933,021.66
加:营业外收入856,684.38856,134.36346,862.92289,299.36
减:营业外支出72,914.2517,033416,463.41339,218.67
利润总额平衡项目0000
五、利润总额83,069,962.5560,164,568.65305,905,863.04195,883,102.35
减:所得税费用4,109,067.775,057,505.4428,087,746.5615,402,533.56
六、净利润78,960,894.7855,107,063.21277,818,116.48180,480,568.79
持续经营净利润78,960,894.7855,107,063.21277,818,116.48180,480,568.79
归属于母公司股东的净利润79,026,078.8255,199,616.28277,824,014.12180,622,954.88
少数股东损益-65,184.04-92,553.07-5,897.64-142,386.09
(一)基本每股收益0.210.140.720.47
(二)稀释每股收益0.210.140.720.47
九、综合收益总额78,960,894.7855,107,063.21277,818,116.48180,480,568.79
归属于母公司股东的综合收益总额79,026,078.8255,199,616.28277,824,014.12180,622,954.88
归属于少数股东的综合收益总额-65,184.04-92,553.07-5,897.64-142,386.09
公告日期2024-08-312024-04-302024-03-292023-10-31
审计意见(境内)标准无保留意见
TOP↑